Nuclear Pirin Functions as a Crucial Mediator of Inflammation in Hepatocellular Carcinoma Development - Takeaway - MDSpire

Nuclear Pirin Functions as a Crucial Mediator of Inflammation in Hepatocellular Carcinoma Development

Share

  • 1

    Pirin (PIR) is significantly upregulated in hepatocellular carcinoma (HCC) and translocates to the nucleus during disease progression.

  • 2

    PIR facilitates ROS-associated long-term inflammation through NF-κB1 and STAT3 pathways, creating a positive feedback loop that accelerates HCC development.

  • 3

    Inhibition of PIR may reduce liver inflammation and ROS production, suggesting it as a potential target for antitumor therapy in HCC.

  • 4

    Patients with high PIR expression have poorer overall survival rates, indicating its clinical relevance in HCC progression.

  • 5

    PIR's role in mediating the crosstalk between ROS and inflammation highlights its importance in the pathogenesis of HCC.

Original Source(s)

Nuclear Pirin Functions as a Crucial Mediator of Inflammation in Hepatocellular Carcinoma Development

  • by Huanhuan Ma, Tingyan Cao, Fengqiong Zhang, Dachao Sun, Lili Chen, Yao Lin, Shuqing Lai, Bin Jiang, Yanming Zhou, Jun You, Xiyao Liu, Yue Wang, Furong Lin, Yuxin Liu, Jinyang Wang, Weiling He, Qinxi Li

  • May 1, 2026

Related Content

Lung Cancer’s Hidden Layers

Study shows that tumor complexity can limit biopsy-based diagnosis

  • April 22, 2026

  • 2 min
Roving Reporter Asks: What Was the Biggest Development in CGT of 2025?

IBTV speaks with industry leaders at the 2025 Meeting on the Mesa to uncover the year’s defining breakthroughs

  • April 22, 2026

  • 1 min
High-Risk Smoldering Multiple Myeloma: BCMA-Directed CAR T-Cell Therapy Shows Activity

A single infusion of the chimeric antigen receptor (CAR) T-cell therapy ciltacabtagene autoleucel led to a 100% measurable residual disease (MRD)-negativity rate in patients with high-risk smoldering ...